Acutaas Chemicals Limited — PPTs, 24-07-2026: Investor Presentation

**1. Business Performance:**

Acutaas Chemicals started FY27 on a strong note, with Q1 revenue up 59.1% YoY to ₹329.7 Cr. Profit (PAT) jumped 70.4% YoY to ₹75.0 Cr, and EBITDA surged 122.1% YoY to ₹113.1 Cr. Growth was primarily driven by robust performance in CDMO and core Advanced Intermediates. Specialty Chemicals saw good growth in BFC, offsetting muted performance in commodity chemicals.

**2. Growth Drivers or Strategy:**

The company's agile business model and strong customer delivery are key drivers. Management aims for 25% full-year revenue growth with stable margins, driven by a better product mix and operational efficiencies.

**3. Recent Developments:**

Acutaas recently earned the 'Great Place to Work' certification, highlighting its positive culture. It also received the 'Responsible Care' certification from the Indian Chemical Council, affirming its commitment to high safety and environmental standards.

**4. Key Financial Metrics:**

Q1 FY27 saw impressive margins with EBITDA at 34.3% and PAT at 22.7%, reflecting operational strengths.

**5. Management Commentary / Outlook:**

Management expressed confidence in achieving 25% revenue growth for the full year, maintaining stable margins.